Clinical Trial Update: The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (NIPA Study) is evaluating whether naloxegol can prevent opioid-induced gastrointestinal motility disturbances in patients with traumat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: University Hospital, Brest | Conditions: Brain Injuries | Phase 3 | Status: RECRUITING